Acumen Pharmaceuticals, Inc. (ABOS) stock
ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.23+0.01 (+6.53%)
Close on Nov 17, 2026Market cap $16.64MP/E –Yield –
Acumen Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Acumen Pharmaceuticals's price to book ratio was 0.3× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.3× to 3.6×, with a median of 0.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.3× | −1.1 |
| 2025 | Dec 31, 2025 | 1.4× | +0.9 |
| 2024 | Dec 31, 2024 | 0.5× | −0.3 |
| 2023 | Dec 29, 2023 | 0.8× | −0.3 |
| 2022 | Dec 30, 2022 | 1.1× | −0.1 |
| 2021 | Dec 31, 2021 | 1.2× | – |
See a number that looks wrong?